Using New ILEs in Home Care: Critical Issues for Safety and Efficacy (CE Symposium)
To claim your credit for the symposium, please click Register/Take Course.
Tuesday, March 26, 2024
7:15 AM – 7:45 AM CT Registration and Breakfast
7:45 AM – 8:45 AM CT CE Symposium
Salons J/K, 6th Floor
500 East 4th Street
This educational activity is intended for pharmacists, nurses, and dietitians engaged in the care of adult and pediatric home-based patients requiring parenteral nutrition.
After completing this activity, participants will be better able to:
- Select the appropriate dose of various intravenous lipid emulsions to prevent essential
fatty acid deficiency in adult and pediatric home-based patients
- Demonstrate appropriate management of intravenous lipid emulsions in adult home-based patients
- Identify appropriate solutions using newer intravenous lipid emulsions that ensure stability and compatibility
Carol S. Ireton-Jones, PhD, RD, CNSC, FASPEN
|Reid Nishikawa, PharmD, FASPEN, FCSHP
Nutrition Support Consultant
Granite Bay, California
Amedco LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to Amedco policy. Amedco LLC is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Carol S. Ireton-Jones, PhD, RD, is on the speakers bureau for Fresenius Kabi USA and Vision2Voice Healthcare Communications.
Reid Nishikawa, PharmD, is a consultant for Bard; and is on the speakers bureau for Fresenius Kabi USA.
Planners, Managers, and Writers
MedEdicus planners and managers have no relevant commercial relationships to disclose.
Learners must complete an evaluation form to receive a certificate of completion. You must attend the entire symposium as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
For Pharmacists and Nurses
Interprofessional Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 knowledge-based CPE contact hour.
Event UAN: Pending
The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Dietitians (CDR) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 CPEU.
Disclosure of Commercial Support
This continuing education activity is supported through an educational grant from Fresenius Kabi USA.
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at firstname.lastname@example.org.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or Fresenius Kabi USA.
©2024 MedEdicus LLC. 317
- 1.00 ACPE
- 1.00 ANCC
- 1.00 CDR